高级检索
当前位置: 首页 > 详情页

C-reactive protein, gamma-glutamyltransferase and type 2 diabetes in a Chinese population

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Capital Med Unv, Beijing Tongren Hosp, Dept Lab Med, Beijing 100730, Peoples R China [2]Capital Med Unv, Beijing Tongren Eye Ctr, Beijing 100730, Peoples R China [3]Handan Eye Hosp, Handan, Hebei, Peoples R China [4]Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3010, Australia [5]Natl Univ Singapore, Singapore Eye Res Inst, Singapore 117548, Singapore
出处:
ISSN:

关键词: C-reactive protein Gamma-glutamyltransferase Diabetes mellitus

摘要:
Background: We studied the association of C-reactive protein (CRP). gamma-glutamyltransferase (GGT) and type 2 diabetes in Chinese. Method: A population-based cross-sectional study. Results: CRP and GGT levels were significantly higher in participants with diabetes than in those without (P<0.001). Higher CRP levels were positively associated with prevalent type 2 diabetes after adjustment for age, sex, smoking, alcohol consumption, physical activity, family history of diabetes, body mass index, waist circumference, waist/hip ratio, education, systolic blood pressure, triglycerides, high density lipoprotein cholesterol, use of antihypertensive drugs, aspirin and lipid-lowering agents, with multivariable odds ratios (OR) of 1.55 (95% confidence interval (CI), 1.05-2.27, P trend=0.005, comparing quartile 4 to quartile 1). However, after further adjustment for GGT, the association was completely attenuated (fourth quartile OR 1.23, 95% CI, 0.83-1.82, P trend = 0.127). Moreover, the association of CRP and prevalent type 2 diabetes was stronger in subjects with GGT values above the median than in those with GGT values below the median. Increasing serum GGT quartiles were positively associated with prevalent type 2 diabetes after adjustment for potential confounding variables (P for trend <0.001). Conclusion: CRP may not be an independent risk factor for type 2 diabetes, at least in Chinese people. Crown Copyright (c) 2009 Published by Elsevier B.V. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2009]版:
大类 | 3 区 医学
小类 | 2 区 医学实验技术
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 医学实验技术
JCR分区:
出版当年[2008]版:
Q1 MEDICAL LABORATORY TECHNOLOGY
最新[2023]版:
Q2 MEDICAL LABORATORY TECHNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2008版] 出版当年五年平均 出版前一年[2007版] 出版后一年[2009版]

第一作者:
第一作者机构: [1]Capital Med Unv, Beijing Tongren Hosp, Dept Lab Med, Beijing 100730, Peoples R China
通讯作者:
通讯机构: [2]Capital Med Unv, Beijing Tongren Eye Ctr, Beijing 100730, Peoples R China [*1]Capital Med Unv, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, 1 DongjiaoMinXiang, Beijing 100730, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:23459 今日访问量:6 总访问量:1282 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)